000 01575 a2200433 4500
005 20250513222305.0
264 0 _c20001128
008 200011s 0 0 eng d
022 _a0027-8424
024 7 _a10.1073/pnas.220398297
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBasler, C F
245 0 0 _aThe Ebola virus VP35 protein functions as a type I IFN antagonist.
_h[electronic resource]
260 _bProceedings of the National Academy of Sciences of the United States of America
_cOct 2000
300 _a12289-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aDogs
650 0 4 _aHumans
650 0 4 _aInfluenza A virus
_xgenetics
650 0 4 _aInterferon Type I
_xantagonists & inhibitors
650 0 4 _aNucleocapsid Proteins
650 0 4 _aNucleoproteins
_xphysiology
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aRibosomes
_xgenetics
650 0 4 _aViral Core Proteins
_xphysiology
650 0 4 _aViral Nonstructural Proteins
_xgenetics
650 0 4 _aVirus Replication
700 1 _aWang, X
700 1 _aMühlberger, E
700 1 _aVolchkov, V
700 1 _aParagas, J
700 1 _aKlenk, H D
700 1 _aGarcía-Sastre, A
700 1 _aPalese, P
773 0 _tProceedings of the National Academy of Sciences of the United States of America
_gvol. 97
_gno. 22
_gp. 12289-94
856 4 0 _uhttps://doi.org/10.1073/pnas.220398297
_zAvailable from publisher's website
999 _c10972444
_d10972444